Pharmaceutical company Verdemed was the third company to obtain sanitary authorization from Anvisa (Agency for Sanitary Surveillance). The decision was published in the Official Diary of the Union last Friday, 29.
From then on, she will be able to put CBD (Cannabidiol, a therapeutic substance without psychoactives) in pharmacies in the country. Until then, Verdemed’s only way to sell the drugs was import.
“Verdemed completed a three-year investment cycle with the obtaining of health authorization for CBD 50 mg/ml, which should reach pharmacies in the second quarter of next year. In order not to harm doctors and patients, until then, we will maintain the service through RDC 335/2020”, says José Bacellar, founder and CEO of the company.
The first company to get Anvisa’s authorization was Prati-Donnaduzi, in April 2020. A year later, in May, it was Nunature’s turn. Three months later, Promediol, a Swiss company with an arm in Brazil, had the process closed at Anvisa.
She was just waiting for publication in the Official Diary of the Union. The Brazilian team was already celebrating, when they learned that the process took an unexpected path and returned for review. The perspective is that the authorization is still out this year.
In two years, only Prati from Paraná placed products in pharmacies. The first was the CBD 200 mg/ml from Prati sells for R$2.3 thousand. The imported came out, at the time, for half the price. This year, in February, the pharmacist got the approval of two more CBD presentations, the 20 mg/ml (R$280) and the 50 mg/ml (R$687.50) presentations.
CBD 50 mg/ml by Verdemed: import packaging (Photo: disclosure)